Cargando…
Advances in drug delivery system for platinum agents based combination therapy
Platinum-based anticancer agents are widely used as first-line drugs in cancer chemotherapy for various solid tumors. However, great side effects and occurrence of resistance remain as the major drawbacks for almost all the platinum drugs developed. To conquer these problems, new strategies should b...
Autores principales: | Kang, Xiang, Xiao, Hai-Hua, Song, Hai-Qin, Jing, Xia-Bin, Yan, Le-San, Qi, Ruo-Gu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chinese Anti-Cancer Association
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4706518/ https://www.ncbi.nlm.nih.gov/pubmed/26779373 http://dx.doi.org/10.7497/j.issn.2095-3941.2015.0063 |
Ejemplares similares
-
The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents
por: Zhou, Jiabei, et al.
Publicado: (2020) -
Novel Approaches for Concurrent Irradiation in Locally Advanced Cervical Cancer: Platinum Combinations, Non-Platinum-Containing Regimens, and Molecular Targeted Agents
por: Mountzios, Giannis, et al.
Publicado: (2013) -
A novel drug–drug nanohybrid for the self-delivery of porphyrin and cis-platinum
por: Shan, Changfu, et al.
Publicado: (2019) -
Colloidal hydroxyethyl starch for tumor-targeted platinum delivery
por: Xiao, Chen, et al.
Publicado: (2018) -
Efficacy and safety of the combination of paclitaxel and platinum in advanced thymic carcinoma
por: Xu, Jian‐ping, et al.
Publicado: (2015)